MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

Sci Rep · 2023 · PMC10719367 · PMID 38092876

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly significantp = 0.06so close (0.05 < p ≤ 0.1)

However, even after adjusting and correcting our survival model, we noticed a reduced survival rate (nearly significant at p = 0.06) in MASLD patients with a MELD-Na score of 11–20.

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.